Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth C Goode

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Therapeutic Advances in Chronic Disease|January 16, 2016
A review of the medical treatment of primary sclerosing cholangitis in the 21st centuryElizabeth C Goode, Simon M Rushbrook
Gastroenterology|June 26, 2012
Mesenteric fat as a source of CRP and target for bacterial translocation in Crohn's diseaseElizabeth C Goode, Alastair J M Watson
Gastroenterology|April 30, 2013
A rare cause of cholangiopathyElizabeth C Goode, Benedict W Simpson, Simon M Rushbrook
Hepatology (Baltimore, Md.)|September 25, 2019
ReplyElizabeth C Goode, Gideon M Hirschfield, Simon M Rushbrook
Gastroenterology|January 11, 2014
Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier functionElizabeth C Goode, Richard C Warburton, William T H Gelson, et al.
Blood|April 27, 2010
Specific N-linked glycosylation sites modulate synthesis and secretion of von Willebrand factorThomas A J McKinnon, Elizabeth C Goode, Graeme M Birdsey, et al.
Nature Communications|November 6, 2024
Fine-mapping and molecular characterisation of primary sclerosing cholangitis genetic risk lociElizabeth C Goode, Laura Fachal, Nikolaos Panousis, et al.
Hepatology (Baltimore, Md.)|December 20, 2018
Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring SystemElizabeth C Goode, Allan B Clark, George F Mells, et al.
Gut|August 6, 2017
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitisRudi Alberts, Elisabeth M G de Vries, Elizabeth C Goode, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Therapeutic Advances in Chronic Disease|January 16, 2016
A review of the medical treatment of primary sclerosing cholangitis in the 21st centuryElizabeth C Goode, Simon M Rushbrook
Gastroenterology|June 26, 2012
Mesenteric fat as a source of CRP and target for bacterial translocation in Crohn's diseaseElizabeth C Goode, Alastair J M Watson
Gastroenterology|April 30, 2013
A rare cause of cholangiopathyElizabeth C Goode, Benedict W Simpson, Simon M Rushbrook
Hepatology (Baltimore, Md.)|September 25, 2019
ReplyElizabeth C Goode, Gideon M Hirschfield, Simon M Rushbrook
Gastroenterology|January 11, 2014
Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier functionElizabeth C Goode, Richard C Warburton, William T H Gelson, et al.
Blood|April 27, 2010
Specific N-linked glycosylation sites modulate synthesis and secretion of von Willebrand factorThomas A J McKinnon, Elizabeth C Goode, Graeme M Birdsey, et al.
Nature Communications|November 6, 2024
Fine-mapping and molecular characterisation of primary sclerosing cholangitis genetic risk lociElizabeth C Goode, Laura Fachal, Nikolaos Panousis, et al.
Hepatology (Baltimore, Md.)|December 20, 2018
Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring SystemElizabeth C Goode, Allan B Clark, George F Mells, et al.
Gut|August 6, 2017
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitisRudi Alberts, Elisabeth M G de Vries, Elizabeth C Goode, et al.
Pageof 1